DORIS REID: Open Payments
NPI 1376099887 · SIMPSONVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,717 in 133 payments from 16 companies in 2025. Trend: 2023 $5,951 · 2024 $9,496 · 2025 $7,717
Speaker / faculty: $4,020Food & beverage: $3,552Education: $111Travel & lodging: $34
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $4,439 |
| Neurocrine BioSciences, Inc. | 40 | $818 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $610 |
| Vanda Pharmaceuticals Inc. | 13 | $399 |
| ABBVIE INC. | 11 | $249 |
| E.R. Squibb & Sons, L.L.C. | 9 | $248 |
| Otsuka America Pharmaceutical, Inc. | 4 | $228 |
| Alkermes, Inc. | 10 | $205 |
| Viatris Specialty LLC | 1 | $108 |
| Amgen Inc. | 1 | $99 |
Products named: UZEDY, INGREZZA, CAPLYTA, FANAPT, REXULTI, COBENFY, ARISTADA, AUSTEDO XR.
Industry payments across SC — which companies pay providers there.
